{
    "clinical_study": {
        "@rank": "23437", 
        "arm_group": [
            {
                "arm_group_label": "liquid protein supplement", 
                "arm_group_type": "Experimental", 
                "description": "Study subjects will receive standard of care nutrition with the addition of  a liquid protein supplement when the baby is able to tolerate an enteral feeding volume of 40mL/kg/day."
            }, 
            {
                "arm_group_label": "Control group", 
                "arm_group_type": "No Intervention", 
                "description": "Study subjects will receive standard of care nutrition"
            }
        ], 
        "brief_summary": {
            "textblock": "We hypothesize that premature infants who receive their mothers' expressed breast milk\n      supplemented with liquid protein early in their hospitalization will have a growth velocity\n      in the first 28 days of life that is 20% greater than the growth velocity of premature\n      infants that do not receive protein fortification."
        }, 
        "brief_title": "Early Protein Supplementation of Human Milk in Extremely Low Birth Weight Infants", 
        "completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Growth in Premature Infants", 
        "condition_browse": {
            "mesh_term": "Birth Weight"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  inborn at Mount Sinai Medical Center\n\n          -  gestational age between 26 0/7 weeks and 31 6/7 weeks gestation\n\n          -  plan by family for their infant to receive human milk feeds\n\n        Exclusion Criteria:\n\n          -  outborn infants\n\n          -  gestational age < 26 0/7 weeks or > 31 6/7 weeks\n\n          -  major congenital anomalies including cardiac disease, inborn errors of metabolism\n             etc.\n\n          -  sepsis and/or other serious clinical complication precluding initiation of enteral\n             feeds\n\n          -  plan by family for their infant to receive primarily preterm infant formula."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "31 Weeks", 
            "minimum_age": "26 Weeks"
        }, 
        "enrollment": {
            "#text": "92", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 18, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01991613", 
            "org_study_id": "GCO 13-1422"
        }, 
        "intervention": {
            "arm_group_label": "liquid protein supplement", 
            "description": "The liquid protein supplement is already in use.  The purpose of this study is to determine whether using the supplement earlier will lead to improved growth.", 
            "intervention_name": "liquid protein supplement", 
            "intervention_type": "Dietary Supplement", 
            "other_name": "Abbott liquid protein supplement"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "November 21, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "New York", 
                    "country": "United States", 
                    "state": "New York", 
                    "zip": "10029"
                }, 
                "name": "Icahn School of Medicine at Mount Sinai"
            }, 
            "investigator": {
                "last_name": "Andrea Weintraub, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Early Liquid Protein Supplementation of Human Milk in Extremely Low Birth Weight Infants", 
        "overall_contact": {
            "email": "megan.tracy@mountsinai.org", 
            "last_name": "Megan Tracy, MD", 
            "phone": "212-241-6186"
        }, 
        "overall_contact_backup": {
            "email": "andrea.weintraub@mssm.edu", 
            "last_name": "Andrea Weintraub, MD", 
            "phone": "212-241-6186"
        }, 
        "overall_official": {
            "affiliation": "Mount Sinai School of Medicine", 
            "last_name": "Andrea Weintraub, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Growth velocity over the first 28 days of life - Daily weight measurements for the first 28 days of life", 
            "measure": "Growth velocity", 
            "safety_issue": "No", 
            "time_frame": "up to 28 days"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01991613"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Mount Sinai School of Medicine", 
            "investigator_full_name": "Andrea Weintraub", 
            "investigator_title": "Associate Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Extrauterine growth from birth until discharge from the NICU - Weekly weight  measurements until discharge from the NICU", 
                "measure": "weight", 
                "safety_issue": "No", 
                "time_frame": "average 11 weeks"
            }, 
            {
                "description": "Extrauterine growth from birth until discharge from the NICU - Weekly length measurements until discharge from the NICU", 
                "measure": "Length", 
                "safety_issue": "No", 
                "time_frame": "average 11 weeks"
            }, 
            {
                "description": "Extrauterine growth from birth until discharge from the NICU - Weekly head circumference measurements until discharge from the NICU", 
                "measure": "head circumference", 
                "safety_issue": "No", 
                "time_frame": "average 11 weeks"
            }
        ], 
        "source": "Mount Sinai School of Medicine", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Mount Sinai School of Medicine", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}